FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 856. Adulteration and misbranding of cascara compound tablets and Pentabisarsen ampuls. U. S. v. Max Gold and Irving Levine (Gold Leaf Pharmacal Co.). Plea of guilty. Fine, $500 on counts 2 and 4. Sentence suspended and defendants placed on probation for 1 year on counts 1 and 3. ✖Remove constraint Titles: 856. Adulteration and misbranding of cascara compound tablets and Pentabisarsen ampuls. U. S. v. Max Gold and Irving Levine (Gold Leaf Pharmacal Co.). Plea of guilty. Fine, $500 on counts 2 and 4. Sentence suspended and defendants placed on probation for 1 year on counts 1 and 3. Issue Dates May 1944 ✖Remove constraint Issue Dates: May 1944 Adjudicating Courts Southern District of New York ✖Remove constraint Adjudicating Courts: Southern District of New York

Refine by:

  • 856. Adulteration and misbranding of cascara compound tablets and Pentabisarsen ampuls. U. S. v. Max Gold and Irving Levine (Gold Leaf Pharmacal Co.). Plea of guilty. Fine, $500 on counts 2 and 4. Sentence suspended and defendants placed on probation for 1 year on counts 1 and 3.1